• The initiative’s partners celebrated a virtual event the 30th of April to show the main services of its online platform

Engagement, openness and interaction are relevant values for CARDIOPATCH Project. That is why the European initiative, co-funded by the EU Interreg Sudoe Programme,  has created an inclusive virtual platform that promotes the creation of synergies between biotechnology agents and 3D printing sector from Southwestern Europe. 

This platform was presented on the 30th of April in an online event that attracted important actors and stakeholders of the acting area of the project. The partners of the initiative organized this webinar with the main objective of presenting the website of CARDIOPATCH, a dynamic and interactive tool where biomedical industry and 3D printing technologies companies can find networking opportunities and other services. 

Scheduled at 16:00 o’clock (CEST time), the virtual meeting gathered all the members and associate members of the consortium of CARDIOPATCH, representatives of the Interreg Sudoe Programme and other entities that are key stakeholders of the initiative’s developments on regenerative medicine and 3D printing. 

During the event, Felipe Prosper, director of the Navarra University Clinic Cell Therapy Department and  the coordinator of the project, welcomed all the attendees and introduced the initiative’s objectives.

After his intervention, Javier Urtasun, cofounder of GUK communication agency, partner of the communication of the initiative, explained the importance of communication on European projects and the target audiences of CARDIOPATCH project: scientific community, 3D printing providers, public administrations and society. 

After that, Marta Berard, project manager at GUK, presented the main features of the website. The presentation was accompanied by a visual video tutorial that showed in a dynamic and agile way the main sections of the website, putting special attention to the funding opportunities search tool, the OpenLab of Synergies and the capacities map. 

At the end of the webinar, Beatriz Pelacho, scientific coordinator of CARDIOPATCH, made an update of the latest achievements of the project in the therapy model that is being developed in the initiative: a therapeutic solution that can benefit patients with chronic myocardial infarction significantly allowing them to recover from their disease without the need of long-term pharmacological treatments or further hospitalizations. 

In addition, Jon Anakabe, researcher of Leartiker technology centre, presented the advances in the development of a 3D system to produce, cultivate and transport the solution, a cellularized patch. 

CARDIOPATCH Project (Network of Excellence for the development of Advanced Therapies of Myocardial Infarction Treatment based on Regenerative Medicine and 3D Printing) brings together a consortium of partners from Spain, France and Portugal: CUN, CIMA University of Navarra, via the Foundation for Applied Medical Research, the Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, LEARTIKER technology centre, communication agency GUK, Centre Hospitalier Universitaire de Toulouse, the University of Montpellier (UM) - Institut des Biomolécules Max Mousseron (IBMM), GenIbet Biopharmaceuticals and the Instituto de Biologia Experimental e Tecnológica.

The project also has the support of associate partners Viscofan, Sodena and the Nouvelle-Aquitaine, Euskadi, Navarre Euroregion (NAEN).